Tonix Pharmaceuticals Announces Research Collaboration to Develop Precision Medicine Techniques for COVID-19 Vaccines and Therapeutics
Dissecting the Immune Response to SARS-CoV-2 in Healthy Recovered or Asymptomatic Volunteers May Lead to Biomarkers for Tailoring COVID-19 Vaccines and Therapeutics
Potential for Human Monoclonal Antibody COVID-19 Therapeutics to be Developed as a Result of the Collaboration.
today announced it has entered into a research collaboration and option agreement with Columbia University
The research is designed to fill in important gaps in understanding the detailed immune responses to COVID-19, and to provide a foundation upon which to target vaccines and therapeutics to appropriate individuals by precision medicine.
tonixpharma.com/news-events/press-releases/detail/1215/tonix-pharmaceuticals-announces-research-collaboration-to
alphastocknews.com/tonix-pharmaceuticals-tnxp-stock-rockets-on-covid-19-news/3791/
Dissecting the Immune Response to SARS-CoV-2 in Healthy Recovered or Asymptomatic Volunteers May Lead to Biomarkers for Tailoring COVID-19 Vaccines and Therapeutics
Potential for Human Monoclonal Antibody COVID-19 Therapeutics to be Developed as a Result of the Collaboration.
today announced it has entered into a research collaboration and option agreement with Columbia University
The research is designed to fill in important gaps in understanding the detailed immune responses to COVID-19, and to provide a foundation upon which to target vaccines and therapeutics to appropriate individuals by precision medicine.
tonixpharma.com/news-events/press-releases/detail/1215/tonix-pharmaceuticals-announces-research-collaboration-to
alphastocknews.com/tonix-pharmaceuticals-tnxp-stock-rockets-on-covid-19-news/3791/
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.